| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.084 | 0.5 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |